Connect with us

Hi, what are you looking for?

Saturday, Aug 13, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Five-month Hapbee study shows products enhance sleep and recovery

Hapbee technology users saw improvements in quality of sleep, length of sleep, reduced restlessness, and reduced time to fall asleep

Hapbee Sleep Study
Photo via Hapbee

Wearable wellness technology company Hapbee Technologies, Inc. (CVE: HAPB) (OTCMKTS: HAPBF) has completed an initial study that demonstrates its products enhance users’ sleep and recovery.

On Monday, the company announced the results of a five-month study that gathered sleep-related user data while utilizing Hapbee Biostreaming Blends.

Hapbee products digitally mimic two signals designed to increase sleep quality. The first is a signal derived from melatonin — a hormone known to regulate the sleep-wake cycle — and the second is derived from adenosine, a compound known to increase the desire to fall asleep.

Data was collected from Hapbee users who submitted their Oura Ring sleep tracker data, demonstrating the effects of the company’s sleep and relaxation-related blends on users’ sleep patterns.

In the first study analyzing the effects of Hapbee Ultra Low Radiofrequency Energy (ULRE) biostreaming technology, improvements were seen in quality of sleep, length of sleep, reduced restlessness, and reduced time to fall asleep.

Read more: Curaleaf expands CBD edibles portfolio aimed for relaxation and sleeping

Read more: Psilocybin temporarily disrupts stages of the sleep cycle: study

“I am very enthused by our initial Oura Ring study results as they strongly confirm the self-reported and qualitative feedback we regularly receive from users about how Hapbee enhances their sleep and recovery, critical elements to overall wellness,” Hapbee CEO Yona Shtern said in a statement.

In the study, 31 Hapbee users provided the company with five months of Oura Ring sleep tracker biometric data between September 1, 2021, and March 1, 2022. Data from the participants in the study using the Oura Ring were derived from thousands of sleep sessions while enjoying the company’s sleep signals and blends.

Using Hapbee’s melatonin (deep sleep) biostream blends, users’ sleep score increased from an average of 77.78 to 81.81, while rapid eye movement (REM) sleep duration increased by more than 13 minutes per night.

Nightly awake time was reduced by almost eight minutes, indicating that the signal extended the users’ REM sleep, a phase that helps with memory processing and learning. Nightly sleep latency was reduced by approximately three minutes, reducing the amount of time users spent trying to fall asleep.

Read more: Recent cannabis use linked to too much and too little sleep: study

Read more: Dynaleo releases high-CBN gummies to be used as sleep aid

Using Hapbee’s adenosine (bedtime) biostream blends, sleep score increased from an average of 77.93 to 82.87, while nightly sleep latency was reduced by nearly three-and-a-half minutes.

The global sleep aid market is projected to exceed $111 billion by 2030. Hapbee has offices in Montreal, Seattle and Phoenix, and plans to develop new sleep-oriented offerings to help people improve their well-being and enhance how they feel.

“The $100 billion sleep market is a primary focus for Hapbee, and it offers lucrative opportunities for the company’s future growth,” Shtern said.

Company stock was down more than 3 per cent on Tuesday to $0.16 on the Canadian Venture Exchange.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Ryan Garner on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like


The 50mg bottle contains 30mg of CBN and 10mg of THC per mg

Medical and Pharmaceutical

But whether or not the disruption helps with the substance's antidepressant properties still needs further research


Social equity applicants will be prioritized, officials say


The new VPs will oversee marketing, sales, finance and strategy